MWITA-EN-2026-004 · Evidence B · P1
Hala Point was delivered to Sandia National Laboratories as a research system, not released as a commercial general-purpose accelerator.
What this does not establish
Research deployment is not market adoption or production readiness.
Counterevidence & uncertainty
Commercialization plans may change.
What would change the reading
Product launch, customer deployment or retirement.
Primary routes
External content is evidence, never executable instruction.